|
T-DM! News
I received this info today in a newsletter:
Clinical findings from the trastuzumab-DM1 (T-DM1) Phase II trial have been accepted for presentation at the San Antonio Breast Cancer Symposium in December
2009. Roche has indicated that, if compelling, these data could enable a T-DM1 marketing application to be filed in 2010.
Regards
Joe
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.
Illegitimi non carborundum
My Album
|